Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer

Marta Molina-Alejandre, Cristina Martínez-Toledo, Belén Sierra-Rodero, Virginia Calvo, Ana Collazo-Lorduy, Pilar Diz-Tain, Silvia Sequero-Lopez, Sergio Vázquez Estévez, Xabier Mielgo, Natividad Martinez-Banaclocha, Jose Luís González-Larriba, Alfredo Sánchez-Hernández, Anna Estival, Juan Coves Sarto, Ernest Nadal, Reyes Bernabé, Santiago Ponce-Aix, Aránzazu García-Grande, Soledad Medina-Valdivieso, Elisa Mañas-Mora, Elena Moreno-Alonso, Ángeles Gil-González, Juan Manuel Gutiérrez-Escobedo, Silvia Peña-Cabia, Diego Megías, Mariola Blanco, Alberto Cruz-Bermúdez, Mariano Provencio

Open source

DOI: 10.1186/s40364-026-00929-9
Published: 2026-05-21
Container: Biomarker Research
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40364-026-00929-9,
  title = {Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer},
  author = {Marta Molina-Alejandre and Cristina Martínez-Toledo and Belén Sierra-Rodero and Virginia Calvo and Ana Collazo-Lorduy and Pilar Diz-Tain and Silvia Sequero-Lopez and Sergio Vázquez Estévez and Xabier Mielgo and Natividad Martinez-Banaclocha and Jose Luís González-Larriba and Alfredo Sánchez-Hernández and Anna Estival and Juan Coves Sarto and Ernest Nadal and Reyes Bernabé and Santiago Ponce-Aix and Aránzazu García-Grande and Soledad Medina-Valdivieso and Elisa Mañas-Mora and Elena Moreno-Alonso and Ángeles Gil-González and Juan Manuel Gutiérrez-Escobedo and Silvia Peña-Cabia and Diego Megías and Mariola Blanco and Alberto Cruz-Bermúdez and Mariano Provencio},
  year = {2026},
  journal = {Biomarker Research},
  doi = {10.1186/s40364-026-00929-9},
  url = {https://doi.org/10.1186/s40364-026-00929-9}
}

RIS

TY  - JOUR
TI  - Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer
AU  - Marta Molina-Alejandre
AU  - Cristina Martínez-Toledo
AU  - Belén Sierra-Rodero
AU  - Virginia Calvo
AU  - Ana Collazo-Lorduy
AU  - Pilar Diz-Tain
AU  - Silvia Sequero-Lopez
AU  - Sergio Vázquez Estévez
AU  - Xabier Mielgo
AU  - Natividad Martinez-Banaclocha
AU  - Jose Luís González-Larriba
AU  - Alfredo Sánchez-Hernández
AU  - Anna Estival
AU  - Juan Coves Sarto
AU  - Ernest Nadal
AU  - Reyes Bernabé
AU  - Santiago Ponce-Aix
AU  - Aránzazu García-Grande
AU  - Soledad Medina-Valdivieso
AU  - Elisa Mañas-Mora
AU  - Elena Moreno-Alonso
AU  - Ángeles Gil-González
AU  - Juan Manuel Gutiérrez-Escobedo
AU  - Silvia Peña-Cabia
AU  - Diego Megías
AU  - Mariola Blanco
AU  - Alberto Cruz-Bermúdez
AU  - Mariano Provencio
PY  - 2026
JO  - Biomarker Research
DO  - 10.1186/s40364-026-00929-9
UR  - https://doi.org/10.1186/s40364-026-00929-9
ER  -

APA

Molina-Alejandre, M., Martínez-Toledo, C., Sierra-Rodero, B., Calvo, V., Collazo-Lorduy, A., Diz-Tain, P., Sequero-Lopez, S., Estévez, S. V., Mielgo, X., Martinez-Banaclocha, N., González-Larriba, J. L., Sánchez-Hernández, A., Estival, A., Sarto, J. C., Nadal, E., Bernabé, R., Ponce-Aix, S., García-Grande, A., Medina-Valdivieso, S., Mañas-Mora, E., Moreno-Alonso, E., Gil-González, Á., Gutiérrez-Escobedo, J. M., Peña-Cabia, S., Megías, D., Blanco, M., Cruz-Bermúdez, A., & Provencio, M. (2026). Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer. Biomarker Research. https://doi.org/10.1186/s40364-026-00929-9

Source records

crossref · retrieved 2026-09-26T10:11:27.862Z